Cargando…
Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series Vaccine in Pediatric Patients with Predominant Antibody Deficiency
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Mosby, Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895879/ http://dx.doi.org/10.1016/j.jaci.2022.12.613 |
| _version_ | 1784881941686779904 |
|---|---|
| author | Tandon, Megha DiGiacomo, Daniel Rosenberg, Chen Hesterberg, Paul Barmettler, Sara Farmer, Jocelyn |
| author_facet | Tandon, Megha DiGiacomo, Daniel Rosenberg, Chen Hesterberg, Paul Barmettler, Sara Farmer, Jocelyn |
| author_sort | Tandon, Megha |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9895879 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Published by Mosby, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98958792023-02-06 Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series Vaccine in Pediatric Patients with Predominant Antibody Deficiency Tandon, Megha DiGiacomo, Daniel Rosenberg, Chen Hesterberg, Paul Barmettler, Sara Farmer, Jocelyn J Allergy Clin Immunol Article Published by Mosby, Inc. 2023-02 2023-02-03 /pmc/articles/PMC9895879/ http://dx.doi.org/10.1016/j.jaci.2022.12.613 Text en Copyright © 2022 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Tandon, Megha DiGiacomo, Daniel Rosenberg, Chen Hesterberg, Paul Barmettler, Sara Farmer, Jocelyn Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series Vaccine in Pediatric Patients with Predominant Antibody Deficiency |
| title | Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series Vaccine in Pediatric Patients with Predominant Antibody Deficiency |
| title_full | Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series Vaccine in Pediatric Patients with Predominant Antibody Deficiency |
| title_fullStr | Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series Vaccine in Pediatric Patients with Predominant Antibody Deficiency |
| title_full_unstemmed | Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series Vaccine in Pediatric Patients with Predominant Antibody Deficiency |
| title_short | Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series Vaccine in Pediatric Patients with Predominant Antibody Deficiency |
| title_sort | response to severe acute respiratory syndrome coronavirus 2 initial series vaccine in pediatric patients with predominant antibody deficiency |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895879/ http://dx.doi.org/10.1016/j.jaci.2022.12.613 |
| work_keys_str_mv | AT tandonmegha responsetosevereacuterespiratorysyndromecoronavirus2initialseriesvaccineinpediatricpatientswithpredominantantibodydeficiency AT digiacomodaniel responsetosevereacuterespiratorysyndromecoronavirus2initialseriesvaccineinpediatricpatientswithpredominantantibodydeficiency AT rosenbergchen responsetosevereacuterespiratorysyndromecoronavirus2initialseriesvaccineinpediatricpatientswithpredominantantibodydeficiency AT hesterbergpaul responsetosevereacuterespiratorysyndromecoronavirus2initialseriesvaccineinpediatricpatientswithpredominantantibodydeficiency AT barmettlersara responsetosevereacuterespiratorysyndromecoronavirus2initialseriesvaccineinpediatricpatientswithpredominantantibodydeficiency AT farmerjocelyn responsetosevereacuterespiratorysyndromecoronavirus2initialseriesvaccineinpediatricpatientswithpredominantantibodydeficiency |